190 results on '"Brandimarte, G."'
Search Results
2. EPASCORE: A new indicator for prescriptive appropriateness of antimicrobials: our experience
3. The “Cristo Re” hospital experience on telerehabilitation for treatment post thyroidectomy neck pain
4. Combined Overview on Diverticular Assessment:a new score for the management of diverticular disease
5. P530 Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-up
6. T.07.10 PERFORMANCE OF A MULTI-COMPOUNDS NUTRACEUTICAL FORMULATION IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE
7. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study
8. Predictive value of the “DICA” classification on the outcome of diverticular disease of the colon: an international study: 3.14
9. The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study
10. Assessment of the nutritional status in patients with acute diverticulitis
11. Benchmarking between two different hospitals on health risk management in the covid-19 emergency
12. Predictive value of the ‘DICA’ classification on the outcome of diverticular disease of the colon: 2.14
13. COVID-19 and the Global Impact on Colorectal Practice and Surgery
14. T01.01.14 THE ROLE OF A NON-INVASIVE TEST IN THE MANAGEMENT OF UPPER-GI DISEASES: COMPARISON BETWEEN SEROLOGY AND ENDOSCOPIC FINDINGS IN A SAMPLE OF 3,795 PATIENTS
15. OC.08.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS: AN INTERNATIONAL STUDY
16. T04.01.12 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE SETTING: AN EXPERIENCE IN NORTH – EAST ITALY POPULATION
17. T01.01.24 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: A 8 YEARS POPULATION STUDY IN NORTHERN ITALY
18. T02.01.7 IS HELICOBACTER PYLORI CURE A LONG-LIFE STRATEGY? A 25 YEARS SURVEY ON 693 PATIENTS
19. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY
20. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY
21. T01.02.19 IS IT POSSIBILE TO WITHDRAW PPIS THERAPY IN GERD PATIENTS? A PROSPECTIVE STUDY ON 216 PATIENTS USING A SECOND GENARTION BARRIER DRUG
22. OC.08.6 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE: NON-INVASIVE APPROACH FOR THE FRAMING OF INTESTINAL DISEASES
23. T04.02.15 OCCURRENCE OF DIVERTICULAR DISEASE IN COLORECTAL CANCER SCREENING: A 3-YEAR STUDY ON 2,104 PATIENTS
24. T01.01.16 CORRELATION BETWEEN SERUM GASTRIC BIOMARKERS AND HISTOLOGICAL PICTURES OF H. PYLORI INFECTION AND ATROPHIC GASTRITIS: A POPULATION STUDY ON 1,122 PATIENTS
25. OC.08.4 RISK FACTORS FOR ENDOSCOPIC SEVERITY OF DIVERTICULAR DISEASE OF THE COLON AND ITS OUTCOME: A REAL-LIFE CASE-CONTROL STUDY
26. Azathioprine in the maintainance remission in inflammatory bowel disease patients: 7-year follow up
27. DICA endoscopic classification: 2-year analysis from an international, multicenter prospective study
28. P605 Eight-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
29. Course of the diverticular disease: What is changing?
30. International consensus on diverticulosis and diverticular disease. Statements from the 3rd international symposium on diverticular disease
31. Prognostic value of the Diverticular Inflammation and Complication Assessment (DICA) classification
32. P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
33. P.02.29 LONG-TERM EFFICACY OF RIFAXIMIN TO MANAGE THE SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
34. P.02.25 RISK FACTORS FOR COLONIC DIVERTICULOSIS: A STUDY IN PRIMARY CARE SETTING
35. P.01.31 A COMPARISON OF DIFFERENT TREATMENTS FOR SYMPTOMATIC REFLUX ESOPHAGITIS: A REAL-LIFE STUDY
36. OC.05.6 THE PROGNOSTIC VALUE OF A NEW ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE: DICA (DIVERTICULAR INFLAMMATION AND COMPLICATION ASSESSMENT)
37. OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
38. P543 Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
39. Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study
40. Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study
41. Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation
42. P.06.10 NATURAL HISTORY OF GASTRIC ULCER IN A 25 YEARS FOLLOW-UP: ROLE OF HELICOBACTER PYLORI INFECTION AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
43. P.01.22 REFLUX ESOPHAGITIS AFTER H.P. ERADICATION: THE ROLE OF GASTRIC ACID SECRETION
44. P.01.29 GASTRIC ULCER: RISK FACTORS, HELICOBACTER PYLORI INFECTION AND NSAIDS USE IN A SAMPLE OF 256 PEOPLE
45. OC.03.4 IMPACT OF TREATMENTS ON FECAL MICROBIOTA AND FECAL METABOLIC PROFILING IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
46. P.06.24 HISTOLOGICAL GHRELIN EXPRESSION CORRELATES WITH ECL PROLIFERATION AND CHROMOGRANIN A IMMUNOEXPRESSION: A COMPARATIVE STUDY BETWEEN ATROPHIC AND NON-ATROPHIC GASTRITIS
47. P.06.14 EFFECTIVENESS AND SAFETY OF PYLERA ® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY
48. P.05.7 EPIDEMIOLOGY OF DIVERTICULAR DISEASE OF THE COLON: A PRELIMINARY ANALYSIS FROM THE INTERNATIONAL “DICA” PROSPECTIVE STUDY
49. P.01.19 HOMOCYSTEINE IN CHRONIC ATROPHIC GASTRITIS: A STUDY ON IMMUNOHISTOCHEMICAL PATTERNS IN GASTRIC MUCOSA
50. P.02.5 SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTENANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.